22 results
8-K
EX-99.1
BXRXQ
Baudax Bio, Inc.
29 Sep 23
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
7:01am
orphan drug designation to TI-168, which we believe highlights the urgent need for innovation and new therapeutic options for Hemophilia A patients,” said
PRER14A
BXRXQ
Baudax Bio, Inc.
25 Aug 23
Preliminary revised proxy
4:01pm
to seek approval as a biological product may face competition sooner than anticipated. In the U.S., the Biologics Price Competition and Innovation Act … a subtitle called the Biologics Price Competition and Innovation Act of 2009 (“BPCIA”), which created an abbreviated approval pathway for biological
8-K
EX-99.1
BXRXQ
Baudax Bio, Inc.
16 Aug 23
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
8:11am
the first innovation in NMB in decades.”
“We believe the actions we’ve taken during our second quarter and recent weeks are a win for shareholders
DEFA14A
EX-99.1
3s8jgy
9 Aug 23
Additional proxy soliciting materials
5:28pm
DEFA14A
EX-99.2
kcc00b
9 Aug 23
Additional proxy soliciting materials
5:28pm
8-K/A
EX-99.2
3w9u9e xedn
9 Aug 23
Other Events
5:27pm
8-K/A
EX-99.1
ccx0siw
9 Aug 23
Other Events
5:27pm
DEFA14A
szb79 93udks84dq4d
17 Jul 23
Additional proxy soliciting materials
7:05am
8-K
EX-99.1
d1kb9r
17 Jul 23
Other Events
7:00am
8-K
EX-99.1
7w2044rh 7d6uu5j
12 May 23
Baudax Bio Reports First Quarter Financial Results and Provides Business Update
8:16am
8-K
EX-99.1
55dxov5wbr
25 Apr 23
Baudax Bio Announces Positive Top-Line Final Results
9:21am
8-K
EX-99.1
htsbq016tye7b5p6
26 Nov 19
Entry into a Material Definitive Agreement
4:53pm
10-12B/A
EX-99.1
pjkxtn9jmszye7xvj
8 Nov 19
Registration of securities (amended)
4:42pm
10-12B/A
EX-99.1
srwxg
5 Nov 19
Registration of securities (amended)
12:16pm
10-12B
EX-10.21
0nbwg3
22 Oct 19
Registration of securities
5:16pm
10-12B
EX-99.1
ejyy88lvs6vj6j
22 Oct 19
Registration of securities
5:16pm
DRS/A
EX-10.21
2cykarm
7 Oct 19
Draft registration statement (amended)
12:00am